Your browser doesn't support javascript.
loading
Prospective pharmacological methodology for establishing and evaluating anti-cancer drug resistant cell lines.
Yu, Hoon; Kim, Dong-Jin; Choi, Hye-Young; Kim, So Myoung; Rahaman, Md Intazur; Kim, Young-Hoon; Kim, So Won.
Affiliation
  • Yu H; Division of Nephrology, Department of Internal Medicine, GangNeung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
  • Kim DJ; Drug Evaluation Department, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Osong, Cheongju, Republic of Korea.
  • Choi HY; Department of Pharmacology, Catholic Kwandong University College of Medicine, Gangneung, Republic of Korea.
  • Kim SM; Department of Pharmacology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea.
  • Rahaman MI; Bio-Medical Institute of Technology, University of Ulsan, Seoul, Republic of Korea.
  • Kim YH; Department of Pharmacology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea.
  • Kim SW; Bio-Medical Institute of Technology, University of Ulsan, Seoul, Republic of Korea.
BMC Cancer ; 21(1): 1049, 2021 Sep 25.
Article in En | MEDLINE | ID: mdl-34560848
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Resistance, Neoplasm / Cell Line, Tumor / Sunitinib / Antineoplastic Agents Type of study: Observational_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Resistance, Neoplasm / Cell Line, Tumor / Sunitinib / Antineoplastic Agents Type of study: Observational_studies Limits: Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2021 Type: Article